Ser878

Site Information
EATVHDGsEEEDDDy SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3208479

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 )
Disease tissue studied:	liver cancer ( 3 ) , hepatocellular carcinoma ( 3 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 2 ) , HeLa (cervical) ( 4 , 5 ) , Huh1 (hepatic) ( 3 ) , liver ( 1 )

References
1	Bian Y, et al. (2014) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 96, 253-62 24275569 Curated Info
2	Kim JY, et al. (2013) Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells. Proc Natl Acad Sci U S A 110, 12414-9 23836654 Curated Info
3	Tucker M (2009) CST Curation Set: 6661; Year: 2009; Biosample/Treatment: cell line, Huh1/untreated; Disease: liver cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
4	Dephoure N, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105, 10762-7 18669648 Curated Info
5	Ruse CI, et al. (2008) Motif-specific sampling of phosphoproteomes. J Proteome Res 7, 2140-50 18452278 Curated Info